Redefine the clinical trial process
Operating as a single technology platform, the Optum Digital Research Network (DRN) helps simplify and automate how you conduct clinical trials.
Narrator: The clinical trial market as we know it is about to change.
We’re revolutionizing the current state aligned to disparate, slow and often manual processes.
Optum’s vision is to transform the drug development process to one that is centered and grounded in real-world patient behavior and physician practice.
Starting with a clean slate, we worked to eliminate the patchwork of dated systems, methods and approaches that led to delayed enrollment, unpredictable timing and costly errors.
Optum’s groundbreaking Digital Research Network leverages its TrueSource™ technology, which pulls raw patient EMR data from hundreds of research sites and delivers the data as a searchable, seamless, interoperable resource, enabling drug companies to design better protocols, find and enroll patients faster, and follow their outcomes throughout the health journey.
No other company is better positioned to disrupt today’s clinical trial system. We are one of the largest health care provider systems in the US, with more than 7,200 medical clinics and 700 hospital sites.
Our EHR systems are embedded at 80 top Integrated Delivery Networks. We have more than 180 million patients’ claims data, 100 million patients’ EHR data, and data from the 1.2 billion prescriptions we process annually.
And we are working towards integrating new forms of data, like Genomics, with EHR data, allowing faster identifications of new gene and protein targets, and improved understanding of how DNA can predict whether a patient will respond to therapy.
Optum employs skilled scientists and consultants with vast understanding and extensive experience in running trials with high quality, on-time results.
These strengths, combined with our deep relationships working in conjunction with the FDA places Optum at the forefront of providing input towards developing guiding principles for the use of real-world evidence in regulatory decision-making.
Optum’s ability to access this unique network and fold-in the strongest data and analytics expertise will enable us to jointly bring life-saving drugs to the patients who need it most.
Join us in this partnership to bring our shared vision for REAL-TIME, REAL-WORLD health care research for REAL-PATIENTS.
Partner with the Optum Digital Research Network
- Accelerate clinical trials through streaming electronic medical record (EMR) capture at preapproved site partners and an existing network of near real-time streaming electronic health records (EHR).
- Design pragmatic trials building from data elements captured in the normal course of care and from patient profiles available in the system.
- Locate research-ready patients by prescreening for eligibility through our proprietary 91 million unique electronic health records.
- Gain precision and predictability, and redefine eSource by sourcing trial data directly from the EMR.
By improving the accuracy of EHR data in prospective clinical investigations of human drugs and biological products, and medical devices, stakeholders can optimize the efficacy of clinical trials.– FDA New Guidance on the Use of EHR in Clinical Trials